Immunotherapies could change kidney cancer care, studies suggest CNN
Two studies showed that renal cell cancer patients had significantly better outcomes when their treatment combined the targeted therapy drug axitinib, or Inlyta, ...
View full coverage on Google News (CLICK HERE TO READ AND SEE MORE)
0 comments:
Post a Comment